Success Stories: A Senior Research Scientist from India Obtains EB-1B Approval within 9 Days with Premium Processing Service

“Thank you so much for all your help. I am satisfied with my case preparation and my attorney’s effort to understand my case and all the due diligence.”

Case Summary:

With a Ph.D. in pharmaceutical sciences and 9 years of substantial contributions to the field of advanced engineering materials, our client unquestionably has the capabilities to continue his work here in the U.S., focusing on the development of state-of-the-art material and formulation characterization approaches for improving the quality of pharmaceutical formulations used in therapies for major diseases and health outcomes.

He hired North America Immigration Law Group to build an EB-1B (Outstanding Professors and Researchers) petition on his behalf to win him the EB1B approval without any obstacles. Accordingly, we discerned his academic and intended research work thoroughly and affirmed that his research addresses some of our nation’s most pressing issues in developing novel characterization approaches to improve the quality of pharmaceutical formulations used in therapies for major diseases and health outcomes, therefore, we could lead him to EB1B approval. We emphasized the below-mentioned attributes in his EB1B petition packet:

• Because of this strong research background, our client is currently conducting research as a senior research scientist, consistently producing unique and impactful work related to advanced engineering materials and their application in improving pharmaceutical performance and manufacturing.
• In evidence of his research success, we noted that his work has been published (the 9 peer-reviewed scientific articles) in some of the most prestigious, high-impact journals in his field. Moreover, his work has been cited 37 times in other peer-reviewed journal articles. Hence, his efforts are of great interest to improving health and quality of life around the world.
• Furthermore, it was noteworthy to mention his active status in the scientific community as a peer reviewer for highly acclaimed journals. Thus, our client has already conducted at least 52 reviews for journals as well as 75 reviews for the conference. This significant record of success and broad international recognition demonstrates that his findings are both novel and global in the advanced engineering materials research community.
• Strengthening our client’s petition further, we combined six recommendation letters as attested to by other experts in the field. One of them stated the following:

“[Client’s] novel and impactful work on drug delivery, pharmaceutical product performance characterization and optimization, and powder technology has distinguished him as an international leader in the field and significantly impacted subsequent research. It is thus in the interest of the field and the United States that he be able to continue his highly impactful work.”

Considering his substantial improvements in the field, advancing preliminary work on its use in treating a variety of neurodegenerative diseases, his efforts are of great interest to improving health and quality of life around the world. Therefore, we were able to convey this to the USCIS. Thanks to the premium processing upgrade, our client secured his EB1B petition approval just 9 days after we filed his case, proving its expedited process. We thank him for trusting our law firm and permitting us to become an integral part of this success story.